ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 171 filers reported holding ALLOGENE THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.29 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $6,347,000 | – | 251,473 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VV Manager LLC | 5,884,326 | $157,994,000 | 85.68% |
| Coastal Bridge Advisors, LLC | 1,155,717 | $31,031,000 | 9.18% |
| TPG Group Holdings (SBS) Advisors, Inc. | 21,216,306 | $569,658,000 | 8.58% |
| Wildcat Capital Management, LLC | 532,166 | $14,289,000 | 6.18% |
| BAINCO INTERNATIONAL INVESTORS | 355,913 | $9,556,000 | 1.51% |
| Avoro Capital Advisors LLC | 1,128,594 | $30,303,000 | 1.05% |
| Perceptive Advisors | 1,543,790 | $41,450,000 | 0.95% |
| DSAM Partners (London) Ltd | 266,269 | $7,149,000 | 0.89% |
| Capital Impact Advisors, LLC | 64,662 | $1,721,000 | 0.63% |
| SHIKIAR ASSET MANAGEMENT INC | 43,395 | $1,165,000 | 0.46% |